Ownership history in Qube Research & Technologies Ltd · 11 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in PTC THERAPEUTICS INC (PTCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 430,934 | +92,771 | +27.4% | 0.03% | $26.4M | $61.37 |
| 2025 Q2 | ADDED | 338,163 | +41,596 | +14.0% | 0.02% | $16.5M | $48.84 |
| 2025 Q1 | ADDED | 296,567 | +66,436 | +28.9% | 0.02% | $15.1M | $50.96 |
| 2024 Q4 | ADDED | 230,131 | +145,382 | +171.5% | 0.01% | $10.4M | $45.14 |
| 2024 Q3 | ADDED | 84,749 | +53,311 | +169.6% | 0.00% | $3.1M | $37.10 |
| 2024 Q1 | ADDED | 31,438 | +20,962 | +200.1% | 0.00% | $915K | $29.09 |
| 2023 Q3 | REDUCED | 10,476 | -31,178 | -74.8% | 0.00% | $235K | $22.41 |
| 2022 Q3 | ADDED | 41,654 | +28,588 | +218.8% | 0.01% | $2.1M | $50.20 |
| 2021 Q1 | ADDED | 13,066 | +4,227 | +47.8% | 0.01% | $619K | $47.35 |
| 2020 Q4 | ADDED | 8,839 | +2,839 | +47.3% | 0.01% | $539K | $61.03 |
As of 2025 Q4 — sorted by position size